Pentagon chief breaks with Trump, hydroxychloroquine, Warner Music IPO
FT News Briefing
00:00
Intro
This chapter delves into key events such as Warner Music's IPO and the contentious research surrounding hydroxychloroquine. It also addresses a defense official's opposition to military intervention during civil unrest and emphasizes the importance of peaceful protests amid national discussions on police brutality.
Play episode from 00:00
Transcript
